Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Aclaris Therapts (ACRS)
Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 71,503
  • Shares Outstanding, K 70,795
  • Annual Sales, $ 29,750 K
  • Annual Income, $ -86,910 K
  • 60-Month Beta 0.25
  • Price/Sales 2.38
  • Price/Cash Flow N/A
  • Price/Book 0.45
Trade ACRS with:

Options Overview Details

View History
  • Implied Volatility 132.05% ( -27.35%)
  • Historical Volatility 579.99%
  • IV Percentile 70%
  • IV Rank 22.20%
  • IV High 494.95% on 10/26/23
  • IV Low 28.49% on 04/06/23
  • Put/Call Vol Ratio 0.50
  • Today's Volume 57
  • Volume Avg (30-Day) 1,845
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 79,876
  • Open Int (30-Day) 89,124

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.39
  • Number of Estimates 6
  • High Estimate -0.19
  • Low Estimate -0.50
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +4.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5902 +71.13%
on 11/13/23
5.6080 -81.99%
on 11/09/23
-4.4400 (-81.47%)
since 11/08/23
3-Month
0.5902 +71.13%
on 11/13/23
8.2750 -87.79%
on 09/14/23
-6.7800 (-87.03%)
since 09/08/23
52-Week
0.5902 +71.13%
on 11/13/23
18.5400 -94.55%
on 01/30/23
-14.5000 (-93.49%)
since 12/08/22

Most Recent Stories

More News
Aclaris: Q3 Earnings Snapshot

Aclaris: Q3 Earnings Snapshot

ACRS : 1.0100 (+1.00%)
Why Aclaris Therapeutics Stock Soared Nearly 6% on Thursday

A bull on the company became more positive on its prospects.

SF : 65.03 (+2.75%)
ACRS : 1.0100 (+1.00%)
Aclaris: Q2 Earnings Snapshot

Aclaris: Q2 Earnings Snapshot

ACRS : 1.0100 (+1.00%)
2 Low-Priced Stocks That Could Make You Richer

These two low-priced healthcare stocks could skyrocket within the next 12 months.

GILD : 79.02 (+1.24%)
INCY : 54.70 (-0.87%)
VKTX : 18.48 (+2.44%)
AXSM : 70.18 (-0.07%)
MRK : 103.75 (-0.13%)
BMY : 50.31 (+0.30%)
AGEN : 0.7465 (-7.90%)
ACRS : 1.0100 (+1.00%)
Why Aclaris Therapeutics Topped the Market on Tuesday

Investors were cheered by the latest laboratory news from the company.

ACRS : 1.0100 (+1.00%)
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates

Aclaris (ACRS) delivered earnings and revenue surprises of 4.55% and 36.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ACRS : 1.0100 (+1.00%)
ACRX : 0.7286 (-4.53%)
Aclaris: Q1 Earnings Snapshot

Aclaris: Q1 Earnings Snapshot

ACRS : 1.0100 (+1.00%)
Zoetis (ZTS) Q1 Earnings Top Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 3.15% and 0.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ZTS : 184.60 (+1.52%)
ACRS : 1.0100 (+1.00%)
Foghorn Therapeutics Inc. (FHTX) Soars 13.1%: Is Further Upside Left in the Stock?

Foghorn Therapeutics Inc. (FHTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

FHTX : 5.63 (+14.43%)
ACRS : 1.0100 (+1.00%)
BridgeBio, Corcept rise; Aclaris Therapeutics, IAA fall

Stocks that traded heavily or had substantial price changes Monday: BridgeBio, Corcept rise; Aclaris Therapeutics, IAA fall

CORT : 26.54 (-0.71%)
BBIO : 32.52 (-3.24%)
ACRS : 1.0100 (+1.00%)
MO : 41.30 (-0.05%)
CIEN : 44.35 (-4.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription...

See More

Key Turning Points

3rd Resistance Point 1.1060
2nd Resistance Point 1.0730
1st Resistance Point 1.0415
Last Price 1.0100
1st Support Level 0.9770
2nd Support Level 0.9440
3rd Support Level 0.9125

See More

52-Week High 18.5400
Fibonacci 61.8% 11.6832
Fibonacci 50% 9.5651
Fibonacci 38.2% 7.4470
Last Price 1.0100
52-Week Low 0.5902

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar